000			02177 a2200649 4500
005			20250517155451.0
264		0	_c20170828
008			201708s 0 0 eng d
022			_a1532-1827
024	7		_a10.1038/bjc.2017.157 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaciaczyk, D
245	0	0	_aCBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells. _h[electronic resource]
260			_bBritish journal of cancer _cJun 2017
300			_a102-112 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Agents, Alkylating _xtherapeutic use
650	0	4	_aBlotting, Western
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival
650	0	4	_aComputer Simulation
650	0	4	_aDacarbazine _xanalogs & derivatives
650	0	4	_aDatabases, Factual
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aEpithelial-Mesenchymal Transition _xgenetics
650	0	4	_aGlioblastoma _xdrug therapy
650	0	4	_aGlycolysis _xgenetics
650	0	4	_aHumans
650	0	4	_aImmunoglobulin J Recombination Signal Sequence-Binding Protein _xgenetics
650	0	4	_aIsocitrate Dehydrogenase _xgenetics
650	0	4	_aMutation
650	0	4	_aNeoplasm Invasiveness _xgenetics
650	0	4	_aNeoplastic Stem Cells _xmetabolism
650	0	4	_aPrognosis
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aTemozolomide
650	0	4	_aTumor Hypoxia _xgenetics
650	0	4	_aZinc Finger E-box-Binding Homeobox 1 _xmetabolism
700	1		_aPicard, D
700	1		_aZhao, L
700	1		_aKoch, K
700	1		_aHerrera-Rios, D
700	1		_aLi, G
700	1		_aMarquardt, V
700	1		_aPauck, D
700	1		_aHoerbelt, T
700	1		_aZhang, W
700	1		_aOuwens, D M
700	1		_aRemke, M
700	1		_aJiang, T
700	1		_aSteiger, H J
700	1		_aMaciaczyk, J
700	1		_aKahlert, U D
773	0		_tBritish journal of cancer _gvol. 117 _gno. 1 _gp. 102-112
856	4	0	_uhttps://doi.org/10.1038/bjc.2017.157 _zAvailable from publisher's website
999			_c27235877 _d27235877